Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThis change introduces Revision: v3.5.4 on the page, replacing Revision: v3.5.3. It represents an update to the page's versioning metadata and does not modify substantive content or study details.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision label, v3.5.3, has replaced the previous v3.5.2 on the page. This indicates a minor site update to the underlying system or template rather than a change to the study content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the page header.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the page, reflecting a platform update.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page metadata now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.